92 related articles for article (PubMed ID: 12553109)
1. [Reduction of the expansion rate of small abdominal aortic aneurysms with roxithromycin. Results from a randomized controlled trial].
Vammen S; Lindholt JS; Østergaard LJ; Fasting H; Henneberg EW
Ugeskr Laeger; 2002 Dec; 164(50):5916-9. PubMed ID: 12553109
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion.
Vammen S; Lindholt JS; Ostergaard L; Fasting H; Henneberg EW
Br J Surg; 2001 Aug; 88(8):1066-72. PubMed ID: 11488791
[TBL] [Abstract][Full Text] [Related]
3. Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial.
Høgh A; Vammen S; Ostergaard L; Joensen JB; Henneberg EW; Lindholt JS
Vasc Endovascular Surg; 2009; 43(5):452-6. PubMed ID: 19640922
[TBL] [Abstract][Full Text] [Related]
4. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.
Lindholt JS; Henneberg EW; Juul S; Fasting H
Int Angiol; 1999 Mar; 18(1):52-7. PubMed ID: 10392481
[TBL] [Abstract][Full Text] [Related]
5. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms.
Gerdes LU; Lindholt JS; Vammen S; Henneberg EW; Fasting H
Br J Surg; 2000 Jun; 87(6):760-5. PubMed ID: 10848855
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm.
Lindholt JS; Juul S; Vammen S; Lind I; Fasting H; Henneberg EW
Br J Surg; 1999 May; 86(5):634-8. PubMed ID: 10361184
[TBL] [Abstract][Full Text] [Related]
9. Growth rate and associated factors in small abdominal aortic aneurysms.
Vega de Céniga M; Gómez R; Estallo L; Rodríguez L; Baquer M; Barba A
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):231-6. PubMed ID: 16293428
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the criteria for elective surgery in screen-detected abdominal aortic aneurysms.
Scott RA; Kim LG; Ashton HA;
J Med Screen; 2005; 12(3):150-4. PubMed ID: 16156946
[TBL] [Abstract][Full Text] [Related]
11. [Natural history of abdominal aortic aneurysm with and without concomitant chronic obstructive pulmonary disease].
Lindholt JS; Heickendorff L; Antonsen S; Vammen S; Fasting H; Henneberg EW
Ugeskr Laeger; 1999 Aug; 161(33):4627-31. PubMed ID: 10464461
[TBL] [Abstract][Full Text] [Related]
12. Optimal interval screening and surveillance of abdominal aortic aneurysms.
Lindholt JS; Vammen S; Juul S; Fasting H; Henneberg EW
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):369-73. PubMed ID: 11035969
[TBL] [Abstract][Full Text] [Related]
13. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment for small abdominal aortic aneurysms.
Rughani G; Robertson L; Clarke M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009536. PubMed ID: 22972146
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological therapy for patients with abdominal aortic aneurysm.
Assar AN
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):999-1009. PubMed ID: 19673677
[TBL] [Abstract][Full Text] [Related]
16. High-risk and low-risk screening for abdominal aortic aneurysm both reduce aneurysm-related mortality. A stratified analysis from a single-centre randomised screening trial.
Lindholt JS; Juul S; Henneberg EW
Eur J Vasc Endovasc Surg; 2007 Jul; 34(1):53-8. PubMed ID: 17331750
[TBL] [Abstract][Full Text] [Related]
17. The incidence of small abdominal aortic aneurysms and the change in normal infrarenal aortic diameter: implications for screening.
Wilmink AB; Hubbard CS; Day NE; Quick CR
Eur J Vasc Endovasc Surg; 2001 Feb; 21(2):165-70. PubMed ID: 11237791
[TBL] [Abstract][Full Text] [Related]
18. [Optimal interval screening and observation of abdominal aortic aneurysms].
Lindholt JS; Vammen S; Henneberg EW; Fasting H; Juul S
Ugeskr Laeger; 2001 Sep; 163(37):5034-7. PubMed ID: 11573379
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with development of large abdominal aortic aneurysm in middle-aged men.
Lindblad B; Börner G; Gottsäter A
Eur J Vasc Endovasc Surg; 2005 Oct; 30(4):346-52. PubMed ID: 15936229
[TBL] [Abstract][Full Text] [Related]
20. Vascular surgical society of great britain and ireland: immunoglobulin A antibodies against chlamydia pneumoniae are associated with expansion of small abdominal aortic aneurysms and declining ankle blood pressure.
Lindholt JS; Vammen S; Henneberg EW; Fasting H
Br J Surg; 1999 May; 86(5):698. PubMed ID: 10361204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]